IL6 and rheumatoid arthritis: Pro-inflammatory cytokines (e.g. IL1β, IL6, and TNFα), which are systemically enhanced in chronic inflammatory diseases like RA are described to trigger endothelial cells to change their anti-thrombotic properties into a procoagulant state [36].